Estimating Long-Term Crude Probability of Death among Young Breast Cancer Patients: A Bayesian Approach

Author:

Clèries Ramon12,Buxó Maria3,Yasui Yutaka4,Marcos-Gragera Rafael5,Martinez José M.6,Ameijide Alberto7,Galceran Jaume7,Borràs Josep M.12,Izquierdo Àngel58

Affiliation:

1. Catalan Institute of Oncology, Plan for Oncology of the Catalonian Government, IDIBELL, L'Hospitalet de Llobregat - Spain

2. Department of Clinical Sciences, University of Barcelona, Barcelona - Spain

3. Girona Biomedical Research Institute (IDIBGI), Girona - Spain

4. Department of Public Health Sciences, School of Public Health, University of Alberta, Edmonton, Alberta - Canada

5. Girona Cancer Registry and Epidemiology Unit, Plan for Oncology of the Catalonian Government, Catalan Institute of Oncology, Descriptive Epidemiology, Genetics and Cancer Prevention Group, Girona Biomedical Research Institute (IDIBGI), Girona - Spain

6. MC MUTUAL, MC-IT Department and Consulting Area, Barcelona - Spain

7. Tarragona Cancer Registry, Foundation Society for Cancer Research and Prevention, Reus - Spain

8. Department of Medical Oncology, Catalan Institute of Oncology, Doctor Josep Trueta University Hospital, Girona - Spain

Abstract

Aims and Background Bayesian survival analysis was applied to assess the long-term survival and probability of death due to breast cancer (BC) in Girona, the Spanish region with the highest BC incidence. Methods A Bayesian autoregressive model was implemented to compare survival indicators between the periods 1985–1994 and 1995–2004. We assessed the long-term excess hazard of death, relative survival (RS), and crude probability of death due to BC (PBC) up to 20 years after BC diagnosis, reporting the 95% credible intervals (CI) of these indicators. Results Patients diagnosed from 1995 onwards showed lower 20-year excess hazards of death than those diagnosed earlier (RS during 1985–1994: local stage: 76.6%; regional stage: 44.9%; RS during 1995–2004: local stage: 85.2%; regional stage: 57.0%). The PBC after 20 years of BC diagnosis for patients diagnosed in 1995 and after might reach 14.4% (95% CI: 8.9%–21.2%) in local stage and 41.0% (95% CI: 36.1%–47.1%) in regional stage. Conclusions The method presented could be useful when dealing with population-based survival data from a small region. Better survival prospects were found in patients diagnosed after 1994, although we detected a non-decreasing long-term excess hazard of death, suggesting that these patients have higher mortality than the general population even 10 years after the diagnosis of BC.

Publisher

SAGE Publications

Subject

Cancer Research,Oncology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3